Equities
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)1.98
  • Today's Change0.10 / 5.32%
  • Shares traded1.42m
  • 1 Year change-20.16%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of May 31 2024202420232022
ASSETS
Cash And Short Term Investments261449416
Total Receivables, Net1028695
Total Inventory252201246
Prepaid expenses313847
Other current assets, total32----
Total current assets678773804
Property, plant & equipment, net574436600
Goodwill, net2,0092,0092,641
Intangibles, net9159741,278
Long term investments7.861215
Note receivable - long term32103111
Other long term assets5.400.220.31
Total assets4,2224,3075,450
LIABILITIES
Accounts payable1057169
Accrued expenses13110789
Notes payable/short-term debt182318
Current portion long-term debt/capital leases1719868
Other current liabilities, total283336
Total current liabilities299433280
Total long term debt332358520
Total debt367580606
Deferred income tax131167197
Minority interest0.271443
Other liabilities, total171912
Total liabilities7799921,051
SHAREHOLDERS EQUITY
Common stock0.080.070.05
Additional paid-in capital6,1475,7785,382
Retained earnings (accumulated deficit)(2660)(2416)(963)
Treasury stock - common------
Unrealized gain (loss)0----
Other equity, total(43)(47)(21)
Total equity3,4433,3164,399
Total liabilities & shareholders' equity4,2224,3075,450
Total common shares outstanding832657533
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.